Colorcon opens new film coating manufacturing facility in Malaysia
Colorcon provides film coating systems, speciality excipients, controlled release formulations, and controlled atmosphere packaging for the pharmaceutical and nutraceutical industries.
The facility, which spans 200,000ft², will create 30 jobs and serve as a key production centre for the Asia-Pacific market.
The plant features advanced technology and energy-efficient systems, aligning with Colorcon's commitment to quality in the aforementioned sectors.
Colorcon CEO Simon Tasker said: 'We are thrilled to open this world-class facility to support our pharmaceutical customers throughout Asia.
'This investment is aligned with our long-term vision to strengthen and de-risk our supply model for film coatings worldwide. Our goal is to anticipate market growth, adding capacity to ensure we are always a step ahead of demand.'
The new facility marks Colorcon's seventh manufacturing site globally, further expanding its operational footprint.
Colorcon managing director Willem Hoogwater said: 'We're proud to offer superior film coating technology and a world-class facility to this rapidly growing region.
'Malaysia has quickly become an important hub for high-value pharmaceutical manufacturing, and we're proud to support the local economy with an investment like this.'
Colorcon, established in 1961, launched Opadry in 1980, which is claimed to be the first complete film coating system that improved batch uniformity and minimised errors in tablet coating.
Since then, Opadry has evolved into a variety of high-performance film coatings that meet different formulation and manufacturing requirements, such as taste-masking, moisture protection, and regulatory compliance.
In May this year, Colorcon entered into an exclusive distribution agreement with ASHA Cellulose to supply polymer-based products in select international regions, including Europe, the Middle East, Africa, and Northeast and Southeast Asia.
"Colorcon opens new film coating manufacturing facility in Malaysia" was originally created and published by Packaging Gateway, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business of Fashion
2 hours ago
- Business of Fashion
Shiseido's Identity Crisis
10 years ago, Shiseido ratified a new tagline to describe its expansive ambitions to 'Be a Global Winner With Our Heritage,' commencing a period of international expansion that was going well until it wasn't. A perfectly terrible storm was waiting on the horizon. The company's largest markets of Japan, China and the US, alongside travel retail, were hit the hardest; Sephora tweens came and went; major acquisitions were reversed and executives shuffled in and out, unable to stem losses or steward the business forward. 'Shiseido has suffered, I'd say, more than any other beauty conglomerate with the slowdown of the Asia Pacific market,' said Rishum Butt, a beauty industry consultant. Net sales for 2024 totaled ¥990 billion ($6.7 billion), down from $10 billion five years ago, but the loss is more profound — the value of the yen has lost more than a third of its value in that time. 'Things might seem OK' on paper, said Butt, 'but what that's disguising is actually a big[ger] issue, which is that they're overexposed to a market which has no clear sign of recovering anytime soon.' ADVERTISEMENT The latter half of the 2010s was a golden age for Japan's largest and the world's oldest beauty company, which saw sales of over $10 billion and an all-time peak in its stock price. By 2019, it had not only three prized possessions in Shiseido, Clé de Peau and Nars but had made a number of acquisitions to penetrate the US market, including prestige makeup brands Laura Mercier, Bareminerals and Buxom and the skincare label Drunk Elephant, for which they paid nearly $1 billion in 2019. At the same time, the company grew more reliant on its China and travel retail segments, and was about to get rocked by the Covid-19 pandemic like the rest of the world. Ahead of its second-quarter earnings release on Wednesday, investors and analysts are expecting Shiseido to miss expectations once again as the company continues to grapple in the short term with global tariffs and sales slowdowns in the US and Japan. They're also looking for evidence of a turnaround in progress. Shiseido has significantly restructured itself in the past five years, winnowing its global workforce from 48,000 to 33,000 and shedding brands it acquired during a more optimistic time. Even its crown jewel, the ultra luxe line Clé de Peau, is in flux, and now shares a team with brand Shiseido, according to multiple sources. Another source close to the brand insisted the two remain distinct entities. Shiseido did not respond to a request for comment owing to a pre-earnings quiet period. These cost reduction efforts are a 'key discussion point from investors,' said Oliver Matthews, an analyst at investment bank CLSA who covers Shiseido. 'The question is, is it enough? Or something that still requires more work?' Beyond operational issues, the company needs to carve out a definitive place in the global beauty world order. Early in the pandemic, the conglomerate pegged its recovery on the belief that prestige makeup sales would pick back up before it swiftly introduced a new mandate to become the world's number one skin health company. A focus on skincare could lead Shiseido to victory. But in its quest for global domination, it has turned away from its core market. 42 percent of the company's net sales came from Japan in 2017; today, it's 29 percent. Shiseido's difficulty conquering the world's biggest beauty market, the US, paired with its struggles closer to home, suggest that the company's current focus may be too far-reaching. 'Another question is, to what degree should they, in fact, invest in the US and Europe?' Matthews wondered. 'Or should they just focus on their right to win in Asia?' Lost in Translation It is both telling and paradoxical that the best-selling luxury Japanese skincare in the US comes from a brand with little authentic Japanese heritage at all; Tatcha, launched in 2009. The brand's Taiwanese-American founder Vicky Tsai was inspired by the beauty habits of Japanese geisha performers, who blotted their faces with oil-wicking papers and cleansed their makeup with featherweight camellia oil. Tatcha became a hit at Sephora, and sold to Unilever in 2019 for an estimated $500 million. ADVERTISEMENT Shiseido's most successful brands with global appeal are Clé de Peau, which takes pains to look more French than Japanese, and mainline Shiseido, which just launched a $145 serum with whole camellias from the Gotoh Islands. Young consumers don't know Clé de Peau, and may only recognise Shiseido from accompanying their mothers to department store counters, where they themselves would never shop, preferring instead to visit Sephora. This inability to connect with younger consumers, and a desire to win in specialty retail, was largely the inspiration behind Shiseido's 2019 blockbuster purchase of Drunk Elephant, a skincare label with a premium positioning that scaled to a near billion dollar brand without rare botanicals or century and a half-old heritage. But Drunk Elephant was caught up in a now-cautionary tale, becoming quickly adored by Sephora tweens who later moved on to cheaper, more age-appropriate brands. Sales dropped 65 percent in 2024, pulling Shiseido's US earnings with it. Over the past five years, as long as Drunk Elephant has been in the business, Shiseido Americas has cycled through CEOs. There was Marc Rey, who oversaw the Drunk Elephant acquisition, unloaded the three makeup acquisitions to private equity firm Advent International and then resigned in 2020; followed by Ron Gee, the Americas CFO who took over his role until this year, when he was replaced by EMEA CEO Alberto Noé. Poor management aside, the Drunk Elephant episode was 'a strategic misstep,' Butt said. Earlier this year the company announced it would pivot the brand in a more clinical direction, but it remains to be seen if alienated customers will return. Nars has been left to thrive — its Radiant Creamy Concealer is the number one best-selling concealer at Sephora — but it's an open question what will happen to the brand under Shiseido's skin-focussed regime. 'They would like to replicate that initial success with more of their portfolio, but I get the feeling that's an organisational capability, not something you can easily buy,' Matthews said, adding that anchoring its global strategy around acquisitions like L'Oréal has not panned out. Slow to Move Quick Shiseido's greatest asset is its remarkable heritage. Founded in 1872 in Tokyo as a pharmacy that stocked medicines from the global West, the company is arguably the oldest beauty conglomerate in the world. (Procter & Gamble was established in 1808, but didn't mint a beauty product until it launched Ivory soap in 1879.) Despite local competition with Kao and Kosé Corporations, there is no bigger brand name in Japanese beauty than Shiseido. While its home country continues to be the brightest spot in Shiseido's regional overviews, and has been bolstered slightly by the weaker yen and influx of tourists, makeup sales are softening fast: Japan's market is favouring 'daily goods' like groceries or personal care products, wrote Morgan Stanley analyst Wakako Sato in July, with cosmetics 'seeing a surprisingly rapid slowdown in inbound demand.' China's trend toward discounting, and travel retail's continued struggles, both point to issues for Shiseido, said Matthews. But it also has too many brands in its home country, which contributes a smaller and smaller percentage of its global sales. Shiseido's strengths are in its prestige lines like Elixir, which is gaining in China, and Clé de Peau. Both are luxury brands not known for their viral moments or TikTok appeal. Other lines, like the reasonably-priced, sensitive skin-focussed Ihada could be easily transplanted into foreign markets with the power of Shiseido's brand name. ADVERTISEMENT Contrast Shiseido with Kao Corporation, which does the lion's share of its business in Japan but is pushing overseas in buzzy categories like sunscreen — its brand Bioré, known for its watery hero sunscreen, launched into the US in 2024, and is ramping up its foreign manufacturing capabilities in the US, Spain and Germany. Bioré is better primed to compete with popular sunscreens like Beauty of Joseon's Relief Sun ($14) or Ultra Violette's Future Screen ($34) than Shiseido, whose range of sunscreens hover around $50. Shisiedo's Korean peer Amorepacific maintains department store presence via labels such as Sulwhasoo, but its lower-priced lines like Laneige and Innisfree have made a bigger splash overseas. 'All of [Shiseido's] innovation is quite expensive,' Butt said, noting the wave of customer preference toward inexpensive products. 'But they're harming themselves by not having something to occupy that entry-prestige, masstige price point.' The beauty industry has changed faster than anticipated, a fact Shiseido's board has acknowledged: Chairman Yoshihiko Hatanaka, an external director appointed in 2024, cited the company's efforts toward 'dismantling outdated structures that could not adapt to market shifts,' in a dialogue last year. The world's oldest beauty company, remaking itself from within. How long could that take? Sign up to The Business of Beauty newsletter, your complimentary, must-read source for the day's most important beauty and wellness news and analysis.
Yahoo
3 hours ago
- Yahoo
Investing in Bintulu Port Holdings Berhad (KLSE:BIPORT) five years ago would have delivered you a 46% gain
Explore Bintulu Port Holdings Berhad's Fair Values from the Community and select yours Stock pickers are generally looking for stocks that will outperform the broader market. And the truth is, you can make significant gains if you buy good quality businesses at the right price. For example, long term Bintulu Port Holdings Berhad (KLSE:BIPORT) shareholders have enjoyed a 29% share price rise over the last half decade, well in excess of the market return of around 2.2% (not including dividends). Now it's worth having a look at the company's fundamentals too, because that will help us determine if the long term shareholder return has matched the performance of the underlying business. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement. During five years of share price growth, Bintulu Port Holdings Berhad achieved compound earnings per share (EPS) growth of 2.6% per year. This EPS growth is slower than the share price growth of 5% per year, over the same period. This suggests that market participants hold the company in higher regard, these days. That's not necessarily surprising considering the five-year track record of earnings growth. You can see how EPS has changed over time in the image below (click on the chart to see the exact values). Before buying or selling a stock, we always recommend a close examination of historic growth trends, available here. What About Dividends? It is important to consider the total shareholder return, as well as the share price return, for any given stock. The TSR is a return calculation that accounts for the value of cash dividends (assuming that any dividend received was reinvested) and the calculated value of any discounted capital raisings and spin-offs. So for companies that pay a generous dividend, the TSR is often a lot higher than the share price return. As it happens, Bintulu Port Holdings Berhad's TSR for the last 5 years was 46%, which exceeds the share price return mentioned earlier. The dividends paid by the company have thusly boosted the total shareholder return. A Different Perspective While the broader market lost about 0.2% in the twelve months, Bintulu Port Holdings Berhad shareholders did even worse, losing 13% (even including dividends). Having said that, it's inevitable that some stocks will be oversold in a falling market. The key is to keep your eyes on the fundamental developments. On the bright side, long term shareholders have made money, with a gain of 8% per year over half a decade. It could be that the recent sell-off is an opportunity, so it may be worth checking the fundamental data for signs of a long term growth trend. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. For example, we've discovered 1 warning sign for Bintulu Port Holdings Berhad that you should be aware of before investing here. If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of companies that have proven they can grow earnings. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Malaysian exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
3 hours ago
- Yahoo
Investors in Astro Malaysia Holdings Berhad (KLSE:ASTRO) have unfortunately lost 82% over the last three years
Every investor on earth makes bad calls sometimes. But really bad investments should be rare. So spare a thought for the long term shareholders of Astro Malaysia Holdings Berhad (KLSE:ASTRO); the share price is down a whopping 83% in the last three years. That'd be enough to cause even the strongest minds some disquiet. And over the last year the share price fell 41%, so we doubt many shareholders are delighted. The falls have accelerated recently, with the share price down 19% in the last three months. While a drop like that is definitely a body blow, money isn't as important as health and happiness. With that in mind, it's worth seeing if the company's underlying fundamentals have been the driver of long term performance, or if there are some discrepancies. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. In his essay The Superinvestors of Graham-and-Doddsville Warren Buffett described how share prices do not always rationally reflect the value of a business. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price. During the three years that the share price fell, Astro Malaysia Holdings Berhad's earnings per share (EPS) dropped by 33% each year. The share price decline of 45% is actually steeper than the EPS slippage. So it seems the market was too confident about the business, in the past. This increased caution is also evident in the rather low P/E ratio, which is sitting at 6.24. The graphic below depicts how EPS has changed over time (unveil the exact values by clicking on the image). We know that Astro Malaysia Holdings Berhad has improved its bottom line lately, but is it going to grow revenue? You could check out this free report showing analyst revenue forecasts. A Different Perspective We regret to report that Astro Malaysia Holdings Berhad shareholders are down 41% for the year. Unfortunately, that's worse than the broader market decline of 0.2%. Having said that, it's inevitable that some stocks will be oversold in a falling market. The key is to keep your eyes on the fundamental developments. Unfortunately, last year's performance may indicate unresolved challenges, given that it was worse than the annualised loss of 12% over the last half decade. We realise that Baron Rothschild has said investors should "buy when there is blood on the streets", but we caution that investors should first be sure they are buying a high quality business. It's always interesting to track share price performance over the longer term. But to understand Astro Malaysia Holdings Berhad better, we need to consider many other factors. To that end, you should learn about the 3 warning signs we've spotted with Astro Malaysia Holdings Berhad (including 2 which are a bit concerning) . If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of companies that have proven they can grow earnings. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Malaysian exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
